March 11, 2025--(BUSINESS WIRE)--Imbed Biosciences ("Imbed"), a pioneer in breakthrough wound care synthetic matrix technology, today announced the U.S. Food and Drug Administration (FDA ...
Investigational Device Exemption (IDE) enables Imbed’s Silver-Gallium, Ultra-Thin Matrix Technology to ... today announced the U.S. Food and Drug Administration (FDA) has approved an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results